TITLE

In This Issue of Diabetes Care

AUTHOR(S)
Resnick, Helaine E.
PUB. DATE
October 2014
SOURCE
Diabetes Care;Oct2014, Vol. 37 Issue 10, p2663
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses various reports published within this issue including one on a study on the effect of albiglutide on diabetic patients, one on the importance of HbA testing to patients with diabetes and one on the effect of fetal hyperglycemia exposure on patients with gestational diabetes mellitus (GDM).
ACCESSION #
98499803

 

Related Articles

  • Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Leung, Lawrence; Birtwhistle, Richard; Kotecha, Jyoti; Hannah, Susan; Cuthbertson, Sharon // British Journal of Nutrition;2009, Vol. 102 Issue 12, p1703 

    It has been estimated that up to one-third of patients with diabetes mellitus use some form of complementary and alternative medicine. Momordica charantia (bitter melon) is a popular fruit used for the treatment of diabetes and related conditions amongst the indigenous populations of Asia, South...

  • Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study. Wernich Thomsen, Reimar; Pedersen, Lars; Møller, Niels; Kahlert, Johnny; Beck-Nielsen, Henning; Toft Sørensen, Henrik // Diabetes Care;Jun2015, Vol. 38 Issue 6, p1089 

    OBJECTIVE To investigate whether the use of incretin-based drugs (GLP-1 receptor agonists, and dipeptidyl peptidase 4 [DPP4] inhibitors) is associated with acute pancreatitis. RESEARCH DESIGN AND METHODS The study was a nationwide population-based case-control study using medical databases in...

  • Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial. Leiter, Lawrence A.; Hwee Teoh; Braunwald, Eugene; Mosenzon, Ofri; Cahn, Avivit; Kumar, K. M. Prasanna; Smahelova, Alena; Hirshberg, Boaz; Stahre, Christina; Frederich, Robert; Bonnici, Francois; Scirica, Benjamin M.; Bhatt, Deepak L.; Raz, Itamar // Diabetes Care;Jun2015, Vol. 38 Issue 6, p1145 

    OBJECTIVE To examine the safety and cardiovascular (CV) effects of saxagliptin in the predefined elderly (≥65 years) and very elderly (≥75 years) subpopulations of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus-Thrombolysis in Myocardial...

  • Long-Term Safety and Efficacy of Empagliflozin, Sitagliptin, and Metformin. FERRANNINI, ELE; BERK, ANDREAS; HANTEL, STEFAN; PINNETTI, SABINE; HACH, THOMAS; WOERLE, HANS J.; BROEDL, ULI C. // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4015 

    OBJECTIVE--To investigate the long-term safety and efficacy of empagliflozin, a sodium glucose cotransporter 2 inhibitor; sitagliptin; and metformin in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS--In this randomized, open-label, 78-week extension study of two 12-week, blinded,...

  • Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. HOLLANDER, PRISCILLA; GUPTA, ALOK K.; PLODKOWSKI, RAYMOND; GREENWAY, FRANK; BAYS, HAROLD; BURNS, COLLEEN; KLASSEN, PRESTON; FUJIOKA, KEN // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4022 

    OBJECTIVE--To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/ 360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with or without background oral antidiabetes drugs. RESEARCH DESIGN AND METHODS--This was a 56-week, double-blind,...

  • Adipose Dipeptidyl Peptidase-4 and Obesity. SELL, HENRIKE; BLUHER, MATTHIAS; KLÖTING, NORA; SCHLICH, RAPHAELA; WILLEMS, MIRIAM; RUPPE, FLORIAN; KNOEFEL, WOLFRAM TRUDO; DIETRICH, ARNE; FIELDING, BARBARA A.; ARNER, PETER; FRAYN, KEITH N.; ECKEL, JURGEN // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4083 

    OBJECTIVE--To study expression of the recently identified adipokine dipeptidyl peptidase-4 (DPP4) in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) of patients with various BMIs and insulin sensitivities, as well as to assess circulating DPP4 in relation to obesity and...

  • Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes. Weinzimer, Stuart A.; Sherr, Jennifer L.; Cengiz, Eda; Kim, Grace; Ruiz, Jessica L.; Carria, Lori; Voskanyan, Gayane; Roy, Anirban; Tamborlane, William V. // Diabetes Care;Oct2012, Vol. 35 Issue 10, p1994 

    OBJECTIVE--Even under closed-loop (CL) conditions, meal-related blood glucose (BG) excursions frequently exceed target levels as a result of delays in absorption of insulin from the subcutaneous site of infusion. We hypothesized that delaying gastric emptying with preprandial injections of...

  • Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY.  // Diabetes Care;Jun2013, Vol. 36 Issue 6, p1749 

    OBJECTIVE--The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial demonstrated that combination therapy with metformin plus rosiglitazone provided superior durability of glycemic control compared with metformin alone, with significantly lower treatment failure rates...

  • Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). NATHAN, DAVID M.; BUSE, JOHN B.; KAHN, STEVEN E.; KRAUSE-STEINRAUF, HEIDI; LARKIN, MARY E.; STATEN, MYRLENE; WEXLER, DEBORAH; LACHIN, JOHN M. // Diabetes Care;Aug2013, Vol. 36 Issue 8, p2254 

    OBJECTIVE--The epidemic of type 2 diabetes (T2DM) threatens to become the major public health problem of this century. However, a comprehensive comparison of the long-term effects of medications to treat T2DM has not been conducted. GRADE, a pragmatic, unmasked clinical trial, aims to compare...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics